Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Robert G, De La Taille A, Descazeaud A (2018) Epidemiology of benign prostatic hyperplasia. Progres Urol: J Assoc Fr Urol Soc Fr Urol 28(15):803–812
2. Foo KT (2019) What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World J Urol 37(7):1293–1296
3. Gravas S, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Tikkinen KAO (2020) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign prostatic obstruction (BPO). EAU guidelines, pp 34–5
4. Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW (2007) A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 52(2):517–522
5. Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR et al (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61(2):317–325